Phospho-FLT1 (Y1213) Polyclon
al Antibody（多克隆抗体） | Phospho-FLT1 (Y1213) Antibody | Phospho-FLT1 (Y1213)抗体- ￥880 - 1320
- CUSABIO
- 武汉
- CSB-PA000751
- 2026年05月27日
- ELISA, WB
- Rabbit
- Human, Mouse, Rat
企业认证
相关产品推荐更多 >
LFNG Polyclonal Antibody（多克隆抗体） | LFNG Antibody | LFNG抗体
￥880
L1TD1 Polyclonal Antibody（多克隆抗体）, FITC conjugated | L1TD1 Antibody, FITC conjugated | L1TD1抗体, FITC conjugated
￥880
Phospho-RPS6KA1/RPS6KA3/RPS6KA2/RPS6KA6 (S221/227/S218/232) Polyclonal Antibody（多克隆抗体） | Phospho-RPS6KA1/RPS6KA3/RPS6KA2/RPS6KA6 (S221/227/S218/232) Antibody | Phospho-RPS6KA1/RPS6KA3/RPS6KA2/RPS6KA6 (S221/227/S218/232)抗体
￥880Phospho-TP53BP1 (S6) Polyclonal Antibody（多克隆抗体） | Phospho-TP53BP1 (S6) Antibody | Phospho-TP53BP1 (S6)抗体
￥880
LSM7 Polyclonal Antibody（多克隆抗体）, Biotin conjugated | LSM7 Antibody, Biotin conjugated | LSM7抗体, Biotin conjugated
￥880
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
细胞污染识别与处理全攻略：5 种常见类型+关键误区Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Synthesized peptide derived from Human Flt-1 around the phosphorylation site of Y1213.
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
-20°C or -80°C
- 克隆性：
多克隆
- 标记物：
Non-conjugated
- 适应物种：
Human, Mouse, Rat
- 抗原来源：
12个月
- 目录编号：
Homo sapiens (Human)
- 供应商：
武汉研升生物科技有限公司
- 宿主：
Rabbit
- 应用范围：
ELISA, WB
- 靶点：
FLT1
- 抗体英文名：
Phospho-FLT1 (Y1213) Antibody
- 抗体名：
Phospho-FLT1 (Y1213) Antibody
- 规格：
100μg/50μg
| 规格： | 100μg | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 50μg | 产品价格： | ￥880.0 |
|
Product Name |
Phospho-FLT1 (Y1213) Antibody |
|
Code |
CSB-PA000751 |
|
Aliases |
EC 2.7.10.1 antibody; FLT 1 antibody; FLT antibody; Flt-1 antibody; FLT1 antibody; Fms like tyrosine kinase 1 antibody; Fms related tyrosine kinase 1 antibody; Fms related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) antibody; Fms related tyrosine kinase 1 vascular endothelial growth factor/vascular permeability factor receptor antibody; Fms-like tyrosine kinase 1 antibody; FRT antibody; Soluble VEGF receptor 1 14 antibody; Soluble VEGFR1 variant 2 antibody; Soluble VEGFR1 variant 21 antibody; Tyrosine protein kinase FRT antibody; Tyrosine protein kinase receptor FLT antibody; Tyrosine-protein kinase FRT antibody; Tyrosine-protein kinase receptor FLT antibody; Vascular endothelial growth factor receptor 1 antibody; Vascular endothelial growth factor vascular permeability factor receptor antibody; Vascular permeability factor receptor 1 antibody; Vascular permeability factor receptor antibody; VEGFR 1 antibody; VEGFR-1 antibody; VEGFR1 antibody; VGFR1_HUMAN antibody |
|
Product Type |
Polyclonal Antibody |
|
Immunogen Species |
Homo sapiens (Human) |
|
Size |
100μg/50μg |
|
Uniprot ID |
P17948 |
|
Immunogen |
Synthesized peptide derived from Human Flt-1 around the phosphorylation site of Y1213. |
|
Host Species |
Rabbit |
|
Species Reactivity |
Human, Mouse, Rat |
|
Tested Applications |
WB, ELISA |
|
Clonality |
Polyclonal |
|
Isotype |
IgG |
|
Conjugate |
Non-conjugated |
|
Buffer |
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
|
Form |
Liquid |
|
Stroage |
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
|
Purification Method |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
|
Target Names |
FLT1 |
|
Research Areas |
Cancer；Cardiovascular;Metabolism;Signal transduction |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Preparation of Carboxypeptidase Y and Its Properties
with a molecular weight of approximately 61000. The absorptivity of the enzyme that is calculated using the A 280nm of a 1%solution is 15. Carboxypeptidase Y is a diisopropyl-phospho-fluoridate (DFP)-sensitive enzyme. Its inactivation by DFP is accompanied
Using Phospho‐Motif Antibodies to Determine Kinase Substrates
comprising both the phosphorylated residue and the surrounding residues that determine kinase specificity, with degenerate residues taking up the remaining positions. Currently, several categories of phospho?motif antibody are commercially available
Optimized Protocol to Make Phospho-Specific Antibodies that Work
, not simply its level of expression. In this review, we will discuss both the design of the phosphopeptide immunogen and immunization. The affinity purification of the phospho-specific antibody as well as the methods most suitable for characterizing
技术资料暂无技术资料 索取技术资料
